Abstract
This paper discusses the hazards of regulating controversial biomedical research in light of the emergence of powerful, multi-national biotechnology corporations. Prohibitions on the use of government funds can simply force controversial research into the private sphere, and unilateral or multilateral research bans can simply encourage multi-national companies to conduct research in countries that lack restrictive laws. Thus, a net effect of government regulation is that research migrates from the public to the private sphere. Because private research receives less oversight and external scrutiny than public research, it can threaten the welfare and rights of human subjects, scientific progress and openness, and the quality of the approval process for new biomedical technologies. In order to avoid the harmful effects of government regulation of biotechnology, society should promote meaningful discussion and dialogue among scientists, industry leaders, and the public before resorting to regulatory solutions. Legislative or executive initiatives should be applied with great discretion and care, and should be crafted in such a way that they protect public health and safety, promote scientific progress, and avoid the hazards of privatized research and polarized debates.
Similar content being viewed by others
References
Altman, K. (1996) Secrecy is HurtingMedical Research, a U.S. Official Says. New York Times (10 February), 11.
Andrews, L. (1999) Legal, Ethical, and Social Concerns in the Debate Over Stem-cell Research. The Chronicle of Higher Education (Jan 29) 45(21),B4.
Annas, G. (1998) Why We Should Ban Human Cloning. New England Journal of Medicine 339, 122–125.
Bagla, P. (1998) Use of Stem Cells Still Legally Murky, But Hearing Offers Hope. Science 282, 1962–1963.
Beardsley, T. (1994) Big-Time Biology. Scientific American 271(5), 90–94.
Berghel, H. (1997) Post Mortem for the Communications Decency Act. Computers and Society 27(4), 8–11.
Brody, B. (1995) Ethical Issues in Drug Testing, Approval, and Pricing. New York: Oxford University Press.
Butler, D. (1998) Human Genome Declaration Looks Set for United Nations Approval. Nature 396, 297.
Campbell, K., McWhire, J., Ritchie, W. and Wilmut, I. (1997) Sheep Cloned by Nuclear Transfer From a Cultured Cell Line. Nature 385, 810–813.
Carey, J., Freudlich, N., Flynn, J. and Gross, N. (1997) The Biotech Century. Business Week (10 March), 79–88.
Clinton, W. (1997) Prohibition on Federal Funding For Cloning Human Beings: Memorandum for the Heads of Executive Departments and Agencies. The White House: Office of the Press Secretary, 4 March.
Cohen, J. (1997) The Genomics Gamble. Science 275, 767–772.
Connolly, F. (1996) A Call For a Statement of Expectations for the Global Information Infrastructure. Science and Engineering Ethics 2, 167–176.
Department of Health and Human Services (1998) Institutional Review Boards: a System in Jeopardy? Washington, DC: DHHS, June.
Enriquez, J. (1998) Genomics and the World's Economy. Science 281, 925–926.
Foster, F. and Shook, R. (1993) Patents, Copyrights, and Trademarks. New York: John Wiley and Sons.
Francis, L. (1998) IRBs and Conflicts of Interest. In R. Spece, D. Shimm and A. Buchanan (Eds.), Conflicts of Interest in Clinical Practice and Research (pp. 418–436). New York: Oxford University Press.
Gearhart, J. (1998) New Potential For Human Embryonic Stem Cells. Science 282, 1061–1062.
Huth, E. (1998) Conflicts of Interest in Industry-Funded Clinical Research. In R. Spece, D. Shimm and A. Buchanan (Eds.), Conflicts of Interest in Clinical Practice and Research (pp. 407–417). New York: Oxford University Press.
Jaffe, A. (1996) Trends and Patterns in Research and Development Expenditures in the United States. Proceedings of the National Academy of Sciences 93, 12658–12663.
Kass, L. (1985) Toward a More Natural Science: Biology and Human Affairs. New York: Free Press.
Kestendbaum, D. (1998) Cloning Plan Spawns Ethics Debate. Science 279, 315.
Kolata, G. (1994) Parkinson Patients Set for First Rigorous Test of Fetal Cell Implants. New York Times (8 February), C3.
Korn, D. (1997) FDA Under Siege: The Public at Risk. Science 276, 1627.
Marshall, E. A. (1998) Versatile Cell Line Raises Scientific Hopes, Legal Questions. Science 282, 1014–1015.
Marshall, E. (1998) Disclosing Data Can Get You in trouble. Science 276, 671–672.
Marshal, E. (1998) Claim of Human-Cow Embryo Greeting with Skepticism. Science 282, 1390–1391.
Marshall, E. (1998) Biomedical Groups Derail Fast-tack Anticloning Bill. Science 279, 1123–1124.
Marshall, E. (1999) Ruling May Free NIH to Fund Stem Cell Studies. Science 283, 465–467.
Marshall, E. and Pennisi, E. (1999) Hubris and the Human Genome. Science 280, 994–995.
Martinez, F., Maillet, R., Legendre, C. and Buisson, C. (1998) Acute Myocardial Infarction Associated with Sildenafil. Lancet 352, 1937.
McCain, K. (1996) Communication, Competition and Secrecy: The Production and Dissemination of Research-Related Information in Genetics. Science, Technology and Human Values 16, 492.
National Bioethics Advisory Commission (1997) (NBAC) Cloning Human Beings: Report and Recommendations. Rockville, MD: National Bioethics Advisory Commission, June.
NBAC (1997) Cloning Human Beings: Report and Recommendations. Rockville,MD
NBAC. Pence, G. (1995) Classic Cases in Medical Ethics, 2nd ed. New York: McGraw Hill.
Pence, G. (1998) Who's Afraid of Human Cloning? Lanham, MD: Rowman and Littlefield.
Pennisi, E. (1997) The Lamb That Roared. Science 278, 2038–2039.
Pennisi, E. (1998) After Dolly, a Pharming Frenzy. Science 279, 646–649.
Presidential Advisory Committed on Human Radiation Experiments (PACHRE). (1996) The Human Radiation Experiments. New York: Oxford University Press.
Priest, S. (1999) Popular Beliefs, Media, and Biotechnology. In S. Friedman, S. Dunwoody and C. Rogers (Eds.), Communicating Uncertainty (pp. 95–112).Mahwah, NJ: Lawrence Earlbaum, 1999.
Ramsey, P. (1970) Fabricated Man: The Ethics of Genetic Control. New Haven: Yale University Press.
Resnik, D. (1998a) The Ethics of Science. New York: Routledge.
Resnik, D. (1998b) Industry-Sponsored Research: Secrecy versus Corporate Responsibility. Business and Society Review 99, 31–34.
Rifkin, J. (1983) Algeny. New York: Viking Press.
Rifkin, J. (1998) The Biotech Century. New York: Putnam.
Sagoff, M. (1999) DNA Patents: Marking Ends Meet. In A. Chapman (Ed.), Perspectives on Genetic Patenting (pp. 245–267). New York: American Association for the Advancement of Science.
Schatz, G. (1998) The Swiss Vote on Gene Technology. Science 281, 1810–1811.
Sheldon, K. (1991) Biotechnics and Society: The Rise of Industrial Genetics. New York: Praeger.
Shenk, D. (1997) Biocapitalism. Harper's Magazine (December), 37–45.
Stix, G. (1997) Profile: Jeremy Rifkin. Scientific American 277(2), 28–32.
The White House, Office of Communications (1997) Directive on Cloning (March 3).
Thomson et al. (1998) Embryonic Stem Cells Derived From Human Blastocysts. Science 282, 1145–1147.
Volti, R. (1995) Society and Technological Change, 3rd edn. New York: St. Martin's Press.
Wade, N. (1998) It's a Three-Legged Race to Decipher the Human Genome. New York Times (23 June), 3.
Wadman, M. (1996) Drug Company Suppressed Publication of Research. Nature (2 May) 381, 4.
Wadman, M. (1999) Congress May Block Stem-cell Research. Nature 397, 639.
Walker, P. (1997) Bill Would Stiffen Rules for Informed Consent. The Chronicle of Higher Education 43(22), A38.
Weston, A. (1997) A Practical Companion to Ethics. New York: Oxford University Press.
Williams, N. (1997) Cloning Sparks Calls for New Laws. Science 275, 1415.
Williams, N. (1998) Agricultural Biotech Faces Backlash in Europe. Science 281, 768–771.
Wilmut, I (1998) Cloning for Medicine. Scientific American (December) 279, 58–63.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Resnick, D.B. Privatized Biomedical Research, Public Fears, and the Hazards of Government Regulation: Lessons from Stem Cell Research. Health Care Analysis 7, 273–287 (1999). https://doi.org/10.1023/A:1009405027357
Issue Date:
DOI: https://doi.org/10.1023/A:1009405027357